Pierre Attali is a highly experienced hepatologist, acting as Senior consultant in hepatology (Paul Brousse Hospital, Villejuif, France) since 1976, where he was recently an active coinvestigator of several phase 2 and phase 3 clinical trials (HCC, NASH, HBV HCV).
Pierre was appointed as an expert for hepatology projects at the European Commission in 2020 and has acted as Principal Investigator of several Phase I-III clinical trials in hepatology since 2000.
During his career, Pierre has held positions as Chief Medical Officer, Chief Operating Officer and Head of R&D across several Biotech companies including Sensorion, Bioalliance Pharma/Onxeo and Selexel; and is currently working as Head of R&D and/or CMO for several biotech companies since January 2019.
Pierre has experience overseeing development of programmes from preclinical research to late phase clinical trials, including the definition and implementation of the medical strategy. Pierre also has experience in the management of Medical Affairs, including pharmacovigilance, and Strategic Marketing, including market access, export activities and competitive intelligence.
